Status:
COMPLETED
Effective Treatments for Dizziness After BPPV: A Clinical Study
Lead Sponsor:
Medipol University
Conditions:
BPPV
Residual Disease
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This clinical study aimed to evaluate how effective vestibular rehabilitation therapy (VRT) and Theta Binaural Beats (T-BB) are in reducing dizziness and anxiety in patients who continue to feel unste...
Detailed Description
Residual dizziness (RD) is a common yet often overlooked condition that can persist after successful canalith repositioning procedures (CRP) for benign paroxysmal positional vertigo (BPPV). Despite th...
Eligibility Criteria
Inclusion
- Diagnosed with unilateral posterior canal benign paroxysmal positional vertigo (BPPV)
- Successfully treated with canalith repositioning procedures (CRP)
- Experiencing persistent dizziness or imbalance lasting at least 20 days after CRP
- Able and willing to perform home-based vestibular rehabilitation exercises
- Provided informed consent to participate in the study
Exclusion
- Presence of other vestibular or neurological disorders (e.g., Meniere's disease, multiple sclerosis)
- History of psychiatric conditions that may interfere with participation
- Use of medications affecting vestibular function or anxiety within the last 4 weeks
- Conductive or sensorineural hearing loss
- Cognitive impairment or inability to follow digital instructions
- Previous participation in vestibular rehabilitation within the past 6 months
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06936345
Start Date
December 1 2023
End Date
January 1 2025
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medipol University
Istanbul, Beykoz, Turkey (Türkiye), 34810